Pharmacovigilance Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global pharmacovigilance market is expected to grow at a CAGR of around 8.6% during 2025-2034. This report on global pharmacovigilance market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global pharmacovigilance market by segmenting the market based on product, service provider, type, process flow, therapeutic area, end use, and region. Also, detailed profiles of companies operating in the pharmacovigilance market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Increased Lifestyle Diseases
• Growing Initiatives by Manufacturers
Market Challenges
• Lack of Skilled Professional
Historical & Forecast Period
Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034
Market by Product
• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV
Market by Service Provider
• In-house
• Contract Outsourcing
Market by Type
• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining
Market by Process Flow
• Case Data Management
Case Logging
Case Data Analysis
Medical Reviewing & Reporting
• Signal Detection
Adverse Event Logging
Adverse Event Analysis
Adverse Event Review & Reporting
• Risk Management System
Risk Evaluation System
Risk Mitigation System
Market by Therapeutic Area
• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Other Areas
Market by End-Use
• Pharmaceuticals
• Biotechnology Companies
• Medical Device Manufacturers
• Others
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Pharmacovigilance Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. Global Pharmacovigilance Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Product
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 4.5. Impact of Russia-Ukraine War
- 5. Global Pharmacovigilance Market by Product
- 5.1. Introduction
- 5.2. Pre-clinical
- 5.3. Phase I
- 5.4. Phase II
- 5.5. Phase III
- 5.6. Phase IV
- 6. Global Pharmacovigilance Market by Service Provider
- 6.1. Introduction
- 6.2. In-house
- 6.3. Contract Outsourcing
- 7. Global Pharmacovigilance Market by Type
- 7.1. Introduction
- 7.2. Spontaneous Reporting
- 7.3. Intensified ADR Reporting
- 7.4. Targeted Spontaneous Reporting
- 7.5. Cohort Event Monitoring
- 7.6. EHR Mining
- 8. Global Pharmacovigilance Market by Process Flow
- 8.1. Introduction
- 8.2. Case Data Management
- 8.2.1. Case Logging
- 8.2.2. Case Data Analysis
- 8.2.3. Medical Reviewing & Reporting
- 8.3. Signal Detection
- 8.3.1. Adverse Event Logging
- 8.3.2. Adverse Event Analysis
- 8.3.3. Adverse Event Review & Reporting
- 8.4. Risk Management System
- 8.4.1. Risk Evaluation System
- 8.4.2. Risk Mitigation System
- 9. Global Pharmacovigilance Market by Therapeutic Area
- 9.1. Introduction
- 9.2. Oncology
- 9.3. Neurology
- 9.4. Cardiology
- 9.5. Respiratory Systems
- 9.6. Other Areas
- 10. Global Pharmacovigilance Market by End-Use
- 10.1. Introduction
- 10.2. Pharmaceuticals
- 10.3. Biotechnology Companies
- 10.4. Medical Device Manufacturers
- 10.5. Other End Uses
- 11. Global Pharmacovigilance Market by Region
- 11.1. Introduction
- 11.2. Europe
- 11.2.1. Germany
- 11.2.2. United Kingdom
- 11.2.3. France
- 11.2.4. Italy
- 11.2.5. Spain
- 11.2.6. Russia
- 11.2.7. Netherlands
- 11.2.8. Rest of the Europe
- 11.3. North America
- 11.3.1. United States
- 11.3.2. Canada
- 11.4. Asia Pacific
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. South Korea
- 11.4.5. Australia
- 11.4.6. Indonesia
- 11.4.7. Rest of the Asia Pacific
- 11.5. Latin America
- 11.5.1. Mexico
- 11.5.2. Brazil
- 11.5.3. Argentina
- 11.5.4. Rest of Latin America
- 11.6. Middle East & Africa
- 11.6.1. Saudi Arabia
- 11.6.2. Turkey
- 11.6.3. Iran
- 11.6.4. United Arab Emirates
- 11.6.5. Rest of Middle East & Africa
- 12. SWOT Analysis
- 13. Porter’s Five Forces
- 14. Market Value Chain Analysis
- 15. Competitive Landscape
- 15.1. Competitive Scenario
- 15.2. Company Profiles
- 15.2.1. Accenture plc
- 15.2.2. ArisGlobal LLC
- 15.2.3. BioClinica Inc.
- 15.2.4. Capgemini
- 15.2.5. ClinChoice (formerly FMD K&L)
- 15.2.6. Cognizant
- 15.2.7. ICON plc.
- 15.2.8. International Business Machines Corporation
- 15.2.9. IQVIA Inc.
- 15.2.10. ITClinical
- 15.2.11. Parexel International Corporation
- 15.2.12. United BioSource LLC
- 15.2.13. Wipro Limited
- List of Figures
- Figure 1: Global Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 2: Global Pharmacovigilance Market by Product, 2024
- Figure 3: Global Pharmacovigilance Market by Service Provider, 2024
- Figure 4: Global Pharmacovigilance Market by Type, 2024
- Figure 5: Global Pharmacovigilance Market by Process Flow, 2024
- Figure 6: Global Pharmacovigilance Market by Therapeutic Area, 2024
- Figure 7: Global Pharmacovigilance Market by End-Use, 2024
- Figure 8: Global Pharmacovigilance Market by Region, 2024
- Figure 9: Global Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 10: Global Pharmacovigilance Market by Product (in %), 2024 & 2034
- Figure 11: Global Pre-clinical Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 12: Global Pre-clinical Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 13: Global Phase I Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 14: Global Phase I Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 15: Global Phase II Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 16: Global Phase II Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 17: Global Phase III Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 18: Global Phase III Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 19: Global Phase IV Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 20: Global Phase IV Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 21: Global Pharmacovigilance Market by Service Provider (in %), 2024 & 2034
- Figure 22: Global In-house Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 23: Global In-house Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 24: Global Contract Outsourcing Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 25: Global Contract Outsourcing Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 26: Global Pharmacovigilance Market by Type (in %), 2024 & 2034
- Figure 27: Global Spontaneous Reporting Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 28: Global Spontaneous Reporting Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 29: Global Intensified ADR Reporting Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 30: Global Intensified ADR Reporting Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 31: Global Targeted Spontaneous Reporting Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 32: Global Targeted Spontaneous Reporting Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 33: Global Cohort Event Monitoring Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 34: Global Cohort Event Monitoring Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 35: Global EHR Mining Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 36: Global EHR Mining Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 37: Global Pharmacovigilance Market by Process Flow (in %), 2024 & 2034
- Figure 38: Global Case Data Management Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 39: Global Case Data Management Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 40: Case Logging Data Management Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 41: Case Data Analysis Data Management Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 42: Medical Reviewing & Reporting Case Data Management Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 43: Global Signal Detection Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 44: Global Signal Detection Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 45: Adverse Event Logging Signal Detection Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 46: Adverse Event Analysis Signal Detection Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 47: Adverse Event Review & Reporting Signal Detection Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 48: Global Risk Management System Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 49: Global Risk Management System Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 50: Evaluation System Risk Management System Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 51: Mitigation System Risk Management System Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 52: Global Pharmacovigilance Market by Therapeutic Area (in %), 2024 & 2034
- Figure 53: Global Oncology Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 54: Global Oncology Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 55: Global Neurology Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 56: Global Neurology Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 57: Global Cardiology Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 58: Global Cardiology Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 59: Global Respiratory Systems Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 60: Global Respiratory Systems Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 61: Global Other Areas Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 62: Global Other Areas Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 63: Global Pharmacovigilance Market by End-Use (in %), 2024 & 2034
- Figure 64: Global Pharmaceuticals Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 65: Global Pharmaceuticals Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 66: Global Biotechnology Companies Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 67: Global Biotechnology Companies Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 68: Global Medical Device Manufacturers Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 69: Global Medical Device Manufacturers Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 70: Global Other End Uses Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 71: Global Other End Uses Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 72: Global Pharmacovigilance Market by Region (in %), 2024 & 2034
- Figure 73: Europe Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 74: Europe Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 75: Europe Pharmacovigilance Market by Country (in %), 2024 & 2034
- Figure 76: Germany Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 77: United Kingdom Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 78: France Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 79: Italy Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 80: Spain Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 81: Russia Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 82: Netherlands Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 83: North America Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 84: North America Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 85: North America Pharmacovigilance Market by Country (in %), 2024 & 2034
- Figure 86: United States Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 87: Canada Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 88: Asia Pacific Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 89: Asia Pacific Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 90: Asia Pacific Pharmacovigilance Market by Country (in %), 2024 & 2034
- Figure 91: China Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 92: Japan Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 93: India Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 94: South Korea Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 95: Australia Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 96: Indonesia Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 97: Latin America Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 98: Latin America Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 99: Latin America Pharmacovigilance Market by Country (in %), 2024 & 2034
- Figure 100: Mexico Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 101: Brazil Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 102: Argentina Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 103: Middle East & Africa Pharmacovigilance Market (in US$ Million), 2020-2024
- Figure 104: Middle East & Africa Pharmacovigilance Market (in US$ Million), 2025-2034
- Figure 105: Middle East & Africa Pharmacovigilance Market by Country (in %), 2024 & 2034
- Figure 106: Saudi Arabia Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 107: Turkey Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 108: Iran Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 109: UAE Pharmacovigilance Market (in US$ Million), 2020-2034
- Figure 110: Market Value Chain
- List of Tables
- Table 1: Global Pharmacovigilance Market Portraiture
- Table 2: Global Pharmacovigilance Market by Product (in US$ Million), 2024 & 2034
- Table 3: Global Pharmacovigilance Market by Service Provider (in US$ Million), 2024 & 2034
- Table 4: Global Pharmacovigilance Market by Type (in US$ Million), 2024 & 2034
- Table 5: Global Pharmacovigilance Market by Process Flow (in US$ Million), 2024 & 2034
- Table 6: Case Data Management Pharmacovigilance Market by Process Flow (in US$ Million), 2024 & 2034
- Table 7: Signal Detection Pharmacovigilance Market by Process Flow (in US$ Million), 2024 & 2034
- Table 8: Risk Management System Pharmacovigilance Market by Process Flow (in US$ Million), 2024 & 2034
- Table 9: Global Pharmacovigilance Market by Therapeutic Area (in US$ Million), 2024 & 2034
- Table 10: Global Pharmacovigilance Market by End-Use (in US$ Million), 2024 & 2034
- Table 11: Global Pharmacovigilance Market by Region (in US$ Million), 2024 & 2034
- Table 12: Europe Pharmacovigilance Market by Country (in US$ Million), 2024 & 2034
- Table 13: North America Pharmacovigilance Market by Country (in US$ Million), 2024 & 2034
- Table 14: Asia Pacific Pharmacovigilance Market by Country (in US$ Million), 2024 & 2034
- Table 15: Latin America Pharmacovigilance Market by Country (in US$ Million), 2024 & 2034
- Table 16: Middle East & Africa Pharmacovigilance Market by Country (in US$ Million),
- 2024 & 2034
- Table 17: List of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook